• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒(SARS-CoV)3CL蛋白酶半胱氨酸蛋白酶的稳态和预稳态动力学评估:催化离子对模型的建立

Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis.

作者信息

Solowiej James, Thomson James A, Ryan Kevin, Luo Chun, He Mingying, Lou Jihong, Murray Brion W

机构信息

Pfizer Global Research and Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, California 92121, USA.

出版信息

Biochemistry. 2008 Feb 26;47(8):2617-30. doi: 10.1021/bi702107v. Epub 2008 Feb 1.

DOI:10.1021/bi702107v
PMID:18237196
Abstract

Severe acute respiratory syndrome (SARS) was a worldwide epidemic caused by a coronavirus that has a cysteine protease (3CLpro) essential to its life cycle. Steady-state and pre-steady-state kinetic methods were used with highly active 3CLpro to characterize the reaction mechanism. We show that 3CLpro has mechanistic features common and disparate to the archetypical proteases papain and chymotrypsin. The kinetic mechanism for 3CLpro-mediated ester hydrolysis, including the individual rate constants, is consistent with a simple double displacement mechanism. The pre-steady-state burst rate was independent of ester substrate concentration indicating a high commitment to catalysis. When homologous peptidic amide and ester substrates were compared, a series of interesting observations emerged. Despite a 2000-fold difference in nonenzymatic reactivity, highly related amide and ester substrates were found to have similar kinetic parameters in both the steady-state and pre-steady-state. Steady-state solvent isotope effect (SIE) studies showed an inverse SIE for the amide but not ester substrates. Evaluation of the SIE in the pre-steady-state revealed normal SIEs for both amide and ester burst rates. Proton inventory (PI) studies on amide peptide hydrolysis were consistent with two proton-transfer reactions in the transition state while the ester data was consistent with a single proton-transfer reaction. Finally, the pH-inactivation profile of 3CLpro with iodoacetamide is indicative of an ion-pair mechanism. Taken together, the data are consistent with a 3CLpro mechanism that utilizes an "electrostatic" trigger to initiate the acylation reaction, a cysteine-histidine catalytic dyad ion pair, an enzyme-facilitated release of P1, and a general base-catalyzed deacylation reaction.

摘要

严重急性呼吸综合征(SARS)是一种由冠状病毒引起的全球性流行病,该病毒具有一种对其生命周期至关重要的半胱氨酸蛋白酶(3CLpro)。采用稳态和预稳态动力学方法结合高活性的3CLpro来表征反应机制。我们发现3CLpro具有与典型蛋白酶木瓜蛋白酶和胰凝乳蛋白酶相同和不同的机制特征。3CLpro介导的酯水解的动力学机制,包括各个速率常数,与简单的双取代机制一致。预稳态猝发速率与酯底物浓度无关,表明对催化作用有很高的倾向性。当比较同源肽酰胺和酯底物时,出现了一系列有趣的观察结果。尽管非酶反应性相差2000倍,但发现高度相关的酰胺和酯底物在稳态和预稳态下具有相似的动力学参数。稳态溶剂同位素效应(SIE)研究表明酰胺底物存在反向SIE,而酯底物不存在。预稳态下SIE的评估显示酰胺和酯猝发速率均存在正常的SIE。对酰胺肽水解的质子累积(PI)研究与过渡态中的两个质子转移反应一致,而酯的数据与单个质子转移反应一致。最后,3CLpro与碘乙酰胺的pH失活曲线表明存在离子对机制。综上所述,这些数据与3CLpro的机制一致,该机制利用“静电”触发来启动酰化反应、半胱氨酸 - 组氨酸催化二元离子对、酶促P1释放以及一般碱催化的脱酰化反应。

相似文献

1
Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis.严重急性呼吸综合征冠状病毒(SARS-CoV)3CL蛋白酶半胱氨酸蛋白酶的稳态和预稳态动力学评估:催化离子对模型的建立
Biochemistry. 2008 Feb 26;47(8):2617-30. doi: 10.1021/bi702107v. Epub 2008 Feb 1.
2
3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.严重急性呼吸综合征冠状病毒的3C样蛋白酶通过一般碱机制催化底物水解。
Biochemistry. 2004 Apr 20;43(15):4568-74. doi: 10.1021/bi036022q.
3
Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.评估严重急性呼吸综合征冠状病毒的3C样蛋白酶活性:药物发现标准化检测方法的建议。
Virus Res. 2008 Apr;133(1):63-73. doi: 10.1016/j.virusres.2007.02.015. Epub 2007 Mar 29.
4
Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics.从稳态和预稳态动力学的溶剂动力学同位素效应确定的克氏锥虫克鲁斯蛋白酶的催化机制
Biochemistry. 2018 Jun 5;57(22):3176-3190. doi: 10.1021/acs.biochem.7b01250. Epub 2018 Feb 2.
5
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.肽醛抑制剂挑战了 SARS-CoV 主蛋白酶的底物特异性。
Antiviral Res. 2011 Nov;92(2):204-12. doi: 10.1016/j.antiviral.2011.08.001. Epub 2011 Aug 11.
6
The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.严重急性呼吸综合征冠状病毒木瓜样蛋白酶:结构、功能及设计的抗病毒化合物对其的抑制作用
Antiviral Res. 2015 Mar;115:21-38. doi: 10.1016/j.antiviral.2014.12.015. Epub 2014 Dec 29.
7
Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease.严重急性呼吸综合征冠状病毒主要蛋白酶催化性半胱氨酸-组氨酸二元组中底物结合诱导两性离子形成的证据。
Biochemistry. 2014 Sep 23;53(37):5930-46. doi: 10.1021/bi400604t. Epub 2014 Sep 7.
8
pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity.阐明 SARS-CoV-2 3-胰凝乳蛋白酶样蛋白酶(3CLpro)的 pH 曲线有助于揭示其催化机制和对活性至关重要的组氨酸残基。
J Biol Chem. 2023 Feb;299(2):102790. doi: 10.1016/j.jbc.2022.102790. Epub 2022 Dec 9.
9
A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase.严重急性呼吸综合征冠状病毒3C样蛋白酶活性位点中酶抑制和肽水解的机制性观点。
J Mol Biol. 2007 Aug 24;371(4):1060-74. doi: 10.1016/j.jmb.2007.06.001. Epub 2007 Jun 8.
10
Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata.用于严重急性呼吸综合征冠状病毒3CL蛋白酶的红移荧光检测法的开发:从热带海洋海绵皱波角海绵中鉴定出一类新型抗严重急性呼吸综合征药物。
Biol Chem. 2006 Aug;387(8):1063-74. doi: 10.1515/BC.2006.131.

引用本文的文献

1
Catalytic Mechanism of SARS-CoV-2 3-Chymotrypsin-Like Protease as Determined by Steady-State and Pre-Steady-State Kinetics.通过稳态和预稳态动力学确定的新型冠状病毒3-胰凝乳蛋白酶样蛋白酶的催化机制
ACS Catal. 2024 Nov 27;14(24):18292-18309. doi: 10.1021/acscatal.4c04695. eCollection 2024 Dec 20.
2
An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo.一种新型口服非共价非肽类 SARS-CoV-2 Mpro 抑制剂可改善病毒复制和体内发病机制。
Cell Rep. 2024 Nov 26;43(11):114929. doi: 10.1016/j.celrep.2024.114929. Epub 2024 Nov 5.
3
Sensitive detection of SARS-CoV-2 main protease 3CL with an engineered ribonuclease zymogen.
用工程化核酶原对 SARS-CoV-2 主蛋白酶 3CL 进行灵敏检测。
Protein Sci. 2024 Apr;33(4):e4916. doi: 10.1002/pro.4916.
4
Understanding Cysteine Chemistry Using Conventional and Serial X-Ray Protein Crystallography.使用传统和串行X射线蛋白质晶体学理解半胱氨酸化学
Crystals (Basel). 2022 Nov;12(11). doi: 10.3390/cryst12111671. Epub 2022 Nov 19.
5
SARS-CoV-2 involvement in central nervous system tissue damage.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与中枢神经系统组织损伤有关。
Neural Regen Res. 2022 Jun;17(6):1228-1239. doi: 10.4103/1673-5374.327323.
6
Inhibition Mechanism of SARS-CoV-2 Main Protease with Ketone-Based Inhibitors Unveiled by Multiscale Simulations: Insights for Improved Designs*.多尺度模拟揭示酮类抑制剂对 SARS-CoV-2 主蛋白酶的抑制机制:改进设计的见解*。
Angew Chem Int Ed Engl. 2021 Dec 1;60(49):25933-25941. doi: 10.1002/anie.202110027. Epub 2021 Nov 3.
7
New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM/MM approach.对 SARS-CoV-2 主蛋白酶催化机制的新认识:一种 ONIOM QM/MM 方法。
Mol Divers. 2022 Jun;26(3):1373-1381. doi: 10.1007/s11030-021-10259-7. Epub 2021 Jun 24.
8
A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.SARS-CoV-2主要蛋白酶受迈克尔受体抑制作用的微观描述。改进抑制剂设计的策略。
Chem Sci. 2021 Jan 29;12(10):3489-3496. doi: 10.1039/d0sc04978f.
9
Molecular modeling of potent novel sulfonamide derivatives as non-peptide small molecule anti-COVID 19 agents.新型强效磺胺衍生物的分子建模作为非肽小分子抗 COVID-19 药物。
J Biomol Struct Dyn. 2022 Sep;40(15):7129-7142. doi: 10.1080/07391102.2021.1897043. Epub 2021 Jun 1.
10
In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和严重急性呼吸综合征冠状病毒(SARS-CoV)的3C样蛋白酶(3CLpro)和非结构蛋白12(nsp12)RNA依赖性RNA聚合酶蛋白进行的选定多药靶向的计算机模拟研究。
Netw Model Anal Health Inform Bioinform. 2021;10(1):22. doi: 10.1007/s13721-021-00299-2. Epub 2021 Mar 25.